Tuo, Jia-Yi
Li, Zhuo-Ying
Shen, Qiu-Ming
Tan, Yu-Ting
Li, Hong-Lan
Xiang, Yong-Bing https://orcid.org/0000-0002-3840-9915
Funding for this research was provided by:
National Key Project of Research and Development Program of China (2021YFC2500404 & 2021YFC2500405)
US National Institutes of Health (UM1 CA182910 (subcontract))
Article History
Received: 17 July 2023
Accepted: 26 October 2023
First Online: 10 January 2024
Declarations
:
: The cohort protocol has been approved by the Institutional Review Boards of the Shanghai Cancer Institute and Vanderbilt University. Informed consent has been obtained from all participants. The current study has been approved by the Renji Hospital Ethics Committee of Shanghai Jiao Tong University School of Medicine (KY2019-197).
: The current manuscript does not contain any individual person’s data.
: The authors have declared no potential conflicts of interest.